Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
| Revenue (Most Recent Fiscal Year) | $3.43M |
| Net Income (Most Recent Fiscal Year) | $-6.99M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.10 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.04 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -197.02% |
| Net Margin (Trailing 12 Months) | -194.14% |
| Return on Equity (Trailing 12 Months) | -66.95% |
| Return on Assets (Trailing 12 Months) | -50.34% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.45 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.27 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 5.20 |
| Book Value per Share (Most Recent Fiscal Quarter) | $9.26 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-35.85 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 1.10M |
| Free Float | 1.10M |
| Market Capitalization | $0.36M |
| Average Volume (Last 20 Days) | 0.85M |
| Beta (Past 60 Months) | 0.41 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.03% |
| Percentage Held By Institutions (Latest 13F Reports) | 22.22% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |